Martindale Pharma, the UK-based international specialty pharmaceutical company, has announced the UK launch of Phenylephrine, a new strength of the selective vasopressor drug for the treatment of hypotension associated with anaesthesia. Phenylephrine will be available in a 10ml ampoule at a strength of 0.1mg/ml. This new strength not only allows for accurate dose dispensing but also [...]
Emma Hamilton, National Training and Development Officer at Scottish Drugs Forum (SDF) has developed the resource in partnership with Greater Glasgow and Clyde Health Board in response to the outbreak of HIV in Glasgow which has affected over 50 people. She commented, ‘My role is in developing harm reduction and emergency responses and HIV has [...]
In December last year, Diurnal completed a successful £30 million IPO on AIM. The Cardiff-based company, which develops innovative approaches to drug delivery, became the third company in Finance Wales’ technology ventures portfolio to be listed on AIM. Diurnal follows in the footsteps of MedaPhor and Q-Chip, which listed following its acquisition by Midatech. Rich [...]
Foam made by tiny frogs could be used to deliver antibiotics to help prevent infections, research involving the University of Strathclyde has found. At the Microbiology Society’s Annual Conference in Liverpool, Strathclyde scientists Dr Paul Hoskisson and Sarah Brozio unveiled their study showing how the foam made by Trinidadian frogs could have important health applications. [...]
A new drug to treat Morquio Syndrome, a rare life-limiting inherited disease, will be available on the Welsh NHS, Health and Social Services Minister Mark Drakeford has announced. The Minister has approved a recommendation from the All Wales Medicines Strategy Group (AWMSG) that Vimizim® (elosulfase alfa) should be available in Wales. Morquio Syndrome is a [...]
Injections IPS Specials have announced a new exclusive distribution partnership for Invicorp Injections (licensed and launched in the UK in 2015). Invicorp (Aviptadil 2mcg / Phentolamine 25mg) intracavernosal injection, is a combination treatment for erectile dysfunction. Indicated for the symptomatic treatment of erectile dysfunction in adult males due to neurogenic, vasculogenic, psychogenic, or mixed aetiology.
World-leading medicinal chemistry and biology at the Universities of Dundee and Cape Town have been allied to the industrial expertise of the Pharmaceuticals Division of Bayer (Germany), one of the world’s leading pharma companies, in an effort to develop critically needed new treatments for tuberculosis (TB). The collaboration combines some of the world’s best knowledge [...]
Bristol-Myers Squibb has announced that the Scottish Medicines Consortium (SMC) has issued guidance which does not recommend the use of Opdivo®q (nivolumab) as monotherapy for the treatment of advanced (unresectable or metastatic) melanoma in adults. The decision will leave Scottish patients with advanced skin cancer without access to this potentially life-extending medicine. In contrast, the [...]
